Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul:72:126977.
doi: 10.1016/j.jtemb.2022.126977. Epub 2022 Mar 26.

Antiviral potential of nanoparticles for the treatment of Coronavirus infections

Joy Sarkar  1 , Sunandana Das  1 , Sahasrabdi Aich  2 , Prithu Bhattacharyya  1 , Krishnendu Acharya  3
Affiliations
Review

Antiviral potential of nanoparticles for the treatment of Coronavirus infections

Joy Sarkar et al. J Trace Elem Med Biol. 2022 Jul.

Erratum in

Abstract

Background: On 31st December 2019 in Wuhan, China, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was acknowledged. This virus spread quickly throughout the world causing a global pandemic. The World Health Organization declared COVID-19 a pandemic disease on 11th March 2020. Since then, the whole world has come together and have developed several vaccines against this deadly virus. Similarly, several alternative searches for pandemic disease therapeutics are still ongoing. One of them has been identified as nanotechnology. It has demonstrated significant promise for detecting and inhibiting a variety of viruses, including coronaviruses. Several nanoparticles, including gold nanoparticles, silver nanoparticles, quantum dots, carbon dots, graphene oxide nanoparticles, and zinc oxide nanoparticles, have previously demonstrated remarkable antiviral activity against a diverse array of viruses.

Objective: This review aims to provide a basic and comprehensive overview of COVID-19's initial global outbreak and its mechanism of infiltration into human host cells, as well as the detailed mechanism and inhibitory effects of various nanoparticles against this virus. In addition to nanoparticles, this review focuses on the role of several antiviral drugs used against COVID-19 to date.

Conclusion: COVID-19 has severely disrupted the social and economic lives of people all over the world. Due to a lack of adequate medical facilities, countries have struggled to maintain control of the situation. Neither a drug nor a vaccine has a 100% efficacy rate. As a result, nanotechnology may be a better therapeutic alternative for this pandemic disease.

Keywords: Antiviral activity; COVID-19; Metal nanoparticles; Nanoparticles; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

On behalf of all listed authors, the corresponding author declares that there is not any sort of financial and non-financial conflict of interest in the subject materials mentioned in this manuscript.

Figures

ga1
Graphical abstract
Fig. 1
Fig. 1
Morphological structure and spike protein visualization of SARS-CoV-2 (Created with BioRender.com).
Fig. 2
Fig. 2
Infiltration mechanism of SARS-CoV-2 inside host cell (Created with BioRender.com).
Fig. 3
Fig. 3
Numerous ways for the creation of nanoparticles (Created with BioRender.com).
Fig. 4
Fig. 4
Physicochemical properties of nanoparticles (Created with BioRender.com).
Fig. 5
Fig. 5
Electron microscopic images of nanoparticles: zinc oxide nanoparticles, gold nanoparticles, silver nanoparticles, selenium nanoparticles, graphene oxide nanoparticles, quantum dots, copper nanoparticles, iron oxide nanoparticles respectively.
See this image and copyright information in PMC

References

    1. Gerba C.P., Betancourt W.Q. Viral aggregation: impact on virus behavior in the environment. Environ. Sci. Technol. 2017;51:7318–7325. doi: 10.1021/acs.est.6b05835. - DOI - PubMed
    1. Rivera A., Messaoudi I. Pathophysiology of ebola virus infection: current challenges and future hopes. ACS Infect. Dis. 2015;1:186–197. doi: 10.1021/id5000426. - DOI - PMC - PubMed
    1. Colpitts C.C., Verrier E.R., Baumert T.F. Targeting viral entry for treatment of hepatitis B and C virus infections. ACS Infect. Dis. 2015;1:420–427. doi: 10.1021/acsinfecdis.5b00039. - DOI - PubMed
    1. Chaudhry R.M., Nelson K.L., Drewes J.E. Mechanisms of pathogenic virus removal in a full-scale membrane bioreactor. Environ. Sci. Technol. 2015;49:2815–2822. doi: 10.1021/es505332n. - DOI - PubMed
    1. Nitsche C., Holloway S., Schirmeister T., Klein C.D. Biochemistry and medicinal chemistry of the dengue virus protease. Chem. Rev. 2014;114:11348–11381. doi: 10.1021/cr500233q. - DOI - PubMed